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Letters to the Editor
9nd colleagues, a split could be not be
chieved in most cases because of severe
ommissural fusion. Tearing of the anterior
eaflet (16/25) was the commonest cause of
R necessitation surgery in their study and
n most other large series.1,3 These data
urther support our findings that severity of
ommissural disease may be the most im-
ortant determinant of production of MR
fter PTMC.
Failure to assess adequately the com-
issural disease might be the reason why
any scoring systems for assessment of
alves for PTMC have poor predictive
alue regarding the outcome and complica-
ions.4 However, echocardiographic assess
ent of commissural morphology has ex-
ellent correlation with outcome.4,5 These
esearchers4 observed that there was mo
requent need for oversizing the balloon in
atients with single or no commissural
plitting. Furthermore, in patients in whom
ommissural splitting could not be achieved
n  4), there was a tear of the anterior
itral leaflet. This corroborates our find-
ngs that, in the presence of severe fusion,
ore pressure is required to split the com-
issures and then areas that offer lesser
esistance can “give way.” Hence, in the
resence of severe commissural fibrosis de-
ected by echocardiography, especially in
he presence of calcified leaflets and thin
nterior leaflets, and given the fact that
alvular disease tends to be underestimated
y echocardiography, PTMC carries an in-
reased risk of leaflet tear.
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loWatch and pseudoaneurysm:
omplication versus coincidence
o the Editor:
ichel-Behnke and colleagues1 reported
he development of pseudoaneurysm of the
ain pulmonary artery after implantation
f an adjustable FloWatch-PAB for pulmo-
ary artery banding.
The observed complication has been re-
orted as subsequent to the device implan-
ation, but no data were available to con-
ider it as consequent to the use of the
evice itself. The authors carefully speci-
ed that “the mechanism of rupture of the
ulmonary artery with pseudoaneurysm
ormation is unclear but might have been
ue to a lesion set during preparation1
heir conclusion was that “careful prepa-
ation of the pulmonary trunk and smooth
lacement of the device around it seem
ssential to prevent aneurysm formation.1
Pseudoaneurysm formation is a well-
nown complication of conventional pulmo-
ary artery banding.2 Although we appreciat
he suggestions proposed by Michel-Behnke
nd colleagues,1 and we could not agr
ore on the importance of a very careful
issection of the pulmonary artery to avoid
“via falsa” for the placement of the band,
e respectfully disagree with the observa-
ion that the FloWatch-PAB could be im-
licated with the mechanism of pseudoan-
urysm formation.
Looking carefully at the available intra-
perative images, the main pulmonary ar-
ery appears with a visible mark like a
revious conventional banding. If this was
he case, the surgical dissection of the adhe-
ions from the previous operation could have
ontributed to the observed complication, in-
ependently from the use of FloWatch-PAB.
lso, the time frame of the formation of the
seudoaneurysm (7 days) is quite unusual for
uch a complication.
scular Surgery ● April 2006Furthermore, among the several advan-
ages of the FloWatch-PAB,3,4 3 in partic
lar are useful to reduce the incidence of
seudoaneurysm formation in comparison
ith the conventional banding. First is the
apability of performing a progressive nar-
owing of the pulmonary artery with a
radual increase of the pressure gradient
hrough the banding, avoiding the trauma-
ism of the sudden constriction of a dilated,
ypertensive, fragile pulmonary artery.3,4
econd is the shape of the device (banana-
ike), allowing a reduction of the cross-
ectional area of the pulmonary artery
ithout modification of the length of the
ircumference of the pulmonary artery it-
elf. This is a major advantage on conven-
ional banding, in which reduction of the
ross-sectional area was obtained with sig-
ificant circumferential reduction of the
ength of the pulmonary arterial wall.5 Be-
ause of the shape of the device, there is not
eed for additional sutures to fix the device to
he wall of the pulmonary artery to prevent
igration, as for the conventional banding.
inally, because of the 2 above advantages,
e were able to show in our animal experi-
ents normal macroscopic and histologic as-
ects of the pulmonary artery in correspon-
ence of the placement of the device up to 14
onths with the device in situ.3
The experimental data have been con-
rmed in the clinical experience, extended
o 26 patients in the combined series of
ausanne and Liverpool, and extended to a
otal number of 67 devices implanted to our
nowledge, with the only pseudoaneurysm
n the case reported by Michel-Behnke and
olleagues.1
Furthermore, the absence of lesions of
he wall of the pulmonary artery has been
ubstantiated by the observation that, as
reviously observed in all animals at the
oment of FloWatch-PAB removal3 and in
ll 12 in the combined series of Lausanne
nd Liverpool who underwent FloWatch-
AB removal at the time of intracardiac
epair, there was no need for pulmonary
rtery reconstruction because the pulmo-
ary artery expanded to the normal size
ith the simple FloWatch-PAB removal5
Antonio F. Corno, MD, FRCS, FACC, FETCS
Marco Pozzi, MD, FRCS, FETCS
Liverpool, United Kingdom
Ludwig K. von Segesser, MD, FACS, FETCS
Lausanne, Switzerland
R1
2
3
4
5
R
W
C t
s
a
u
B
u
i
t
t
v
p
v
t
a
a
p
o
w
t
u
r
r
d
e
o
d
T
h
c
e
m
o
t
t
e
v
m
p
n
t
w
p
R
1
2
3
E
T
w
u
o
b
T
W
n g
s
A
d
t
o
r
l
e
s
c
e
W
h
v
o
p
s
t
c
d
m
E
t
e
m
W
p
i
s
b
r
i
B
c
a
(
D
s
h
s
s
u
O
(
2
n
b
( es
w
c
i

0
a
g
1
t
p
s
p
r
t
t
W
fi
Letters to the Editoreferences
. Michel-Behnke I, Akintuerk H, Valeske K,
Thul J, Mueller M, Schranz D. Pseudoaneu-
rysm of the pulmonary trunk after placement
of an adjustable pulmonary artery banding
device (FloWatch-PAB) in a patient with
muscular ventricular septal defect. J Thorac
Cardiovasc Surg. 2005;130:894-5.
. Cordell AR. Complications of pulmonary ar-
tery debanding.In: Cordell AR, Ellison RG, ed-
itors. Complications of intrathoracic surgery.
Boston: Little, Brown and Company; 1979. p.
162-6.
. Corno AF, Sekarski N, Bernath MA, Payot
M, Tozzi P, von Segesser LK. Pulmonary
artery banding: long-term telemetric adjust-
ment. Eur J Cardiothorac Surg. 2003;23:
317-22.
. Corno AF, Bonnet D, Sekarski N, Sidi D,
Vouhé P, von Segesser LK. Remote control of
pulmonary blood flow: initial clinical experi-
ence. J Thorac Cardiovasc Surg. 2003;126:
1775-80.
. Corno AF, Prosi M, Fridez P, Zunino P,
Quarteroni A, von Segesser LK. No more
pulmonary artery reconstruction after band-
ing. Computational fluid dynamics and clini-
cal evidence. Eur J Cardiothorac Surg. 2006;
29:93-6.
doi:10.1016/j.jtcvs.2005.11.026
eply to the Editor:
e appreciate the thoughtful comments of
orno and associates1 about our recen
tudy. The exciting results pointing out the
dvantages of the FloWatch-PAB2,3 forced
s to use this device in the case presented.
ecause of the localization of the ventric-
lar septal defect in the muscular septum,
ncreased pulmonary artery pressure and
he patient’s young age made us optimistic
hat the adjustable FloWatch banding de-
ice would be the ideal solution for this
atient. For this reason, we avoided a con-
entional banding as suspected by the au-
hors, and even looking thoroughly at all
vailable intraoperative images, we are not
ble to visualize surgical damaging of the
ulmonary artery trunk before placement
f the device. After removal, the device
as carefully studied for any sharp edges
hat might have occurred during the man-
facturing process and could have been
esponsible for the observed pseudoaneu-
ysm formation, which could be ruled out.
However, the early detection of pericar-
ial effusion and the loss of the banding
ffect suggest some damage to the integrity
f the vessel wall while the aneurysm was
etected on radiography only 7 weeks later.
herefore we are confident that the patient
ad a real complication rather than a coin-
idence. We agree that the physical prop- b
Trties of the FloWatch-PAB, especially the
aintenance of the circumferential length
f the pulmonary artery, should be helpful
o prevent the complications of conven-
ional banding procedures. Our personal
xperience in 2 other patients with multiple
entricular septal defects, in whom we re-
oved the device 16 and 27 months after
lacement, respectively, support the useful-
ess of this new medical implant. Never-
heless, facing even rare complications, as
e described, should contribute to increase
atient safety.
Ina Michel-Behnke, MD
Hakan Akintuerk, MD
Dietmar Schranz, MD
Pediatric Heart Center
Justus-Liebig University
Giessen, Germany
eferences
. Michel-Behnke I, Akintuerk H, Valeske K,
Thul J, Mueller M, Schranz D. Pseudoaneu-
rysm of the pulmonary trunk after placement
of an adjustable pulmonary artery banding
device (FloWatch-PAB) in a patient with
muscular ventricular septal defect. J Thorac
Cardiovasc Surg. 2005;130:894-5.
. Corno AF, Bonnet D, Sekarski N, Sidi D,
Vouhe P, Von Segesser LK. Remote control
of pulmonary blood flow: initial clinical ex-
perience. J Thorac Cardiovasc Surg. 2003;
126:1775-80.
. Corno AF, Sekarski N, Bernath MA, Payot
M, Tozzi P, Von Segesser LK. Pulmonary
artery banding: long-term telemetric adjust-
ment. Eur J Cardiothorac Surg. 2003;23:
317-22.
doi:10.1016/j.jtcvs.2005.12.007
valuation of a modified
hermoWrap™ for the Allon™
arming system in patients
ndergoing elective
ff-pump coronary artery
ypass grafting
o the Editor:
e have previously shown in this jour-
al1 that the Allon™ patient-warmin
ystem (Allon™ 2001 system; MTRE
dvanced Technologies Ltd, Or-Akiva In-
ustrial Park, Israel) is efficient in main-
aining normothermia during off-pump cor-
nary artery bypass grafting (OPCABG),
esulting in reduced perioperative blood
oss and transfusion requirements. How-
ver, the ThermoWrap™ used with this
ystem is expensive, complications (ie,
urns) have been described,2 and handling t
he Journal of Thoracic and Cardiovascularan be time consuming. Meanwhile, we
valuated the new version of a Thermo-
rap™ for the Allon™ system in terms of
andling and efficacy. In contrast to the old
ersion of the ThermoWrap™, the design
f the new wrap has been modified to im-
rove patient care and to reduce potential
kin damage, as well as costs. With insti-
utional approval and informed consent, 40
onsecutive patients (mean age  standard
eviation [SD], 68  10 years; mean body
ass index SD, 28 5 kg · m2; mean
uroscore  SD, 6  3) undergoing elec-
ive OPCABG were randomly assigned to
ither the original (group A, n  20) or the
odified (group B, n  20) Thermo-
rap™. According to our previous tem-
erature measurement study,1 active warm-
ng was started after induction of anesthe-
ia, with the Allon™ system set to 36.9°C
ody core temperature (BCT). BCT was
ecorded every 30 minutes during surgical
ntervention, and maximal intraoperative
CT decrease, as well as increase, was
alculated. Skin alterations (reddening) were
ssessed by using a visual analog scale
score, 1-10) at the end of the procedure.
uring the clinical evaluation, 15 involved
taff members completed a questionnaire on
andling of the Allon™ system. The an-
wers were recorded by using a Likert
cale (score, 1-4). The Student t test was
sed for statistical analyses. Durations of
PCABG procedures were comparable
group A, 257  59 minutes; group B,
69  53 minutes; P  .89). There was
o significant difference of BCT at the
eginning and end of the intervention
Figure 1). Intraoperative BCT chang
ere significantly different for group A
ompared with group B (BCT decrease/
ncrease: group A, 0.7°C  0.4°C/
1.2°C  0.3°C; group B, 0.4°C 
.3°C/1.0°C  0.3°C; P  .05). Skin
lterations were comparable for both
roups (visual analog scale: group A, 6 
; group B, 6  1; P  .78). According
o 80% of the interviewed staff members,
ositioning of the modified wrap B was
uperior and less time consuming com-
ared with wrap A. On the basis of these
esults, patient management can be fur-
her improved by using the Allon™ sys-
em with the new modified Thermo-
rap™.
This study was performed without any
nancial support from manufacturers or
he pharmaceutical industries. The Allon™
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